๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Ryanodine receptor gene point mutation and malignant hyperthermia susceptibility

โœ Scribed by Isabella Moroni; Elda Fabiola; Gonano Giacomo; Pietro Comi; Vincenzo Tegazzin; Alessandro Prelle; Andreina Bordoni; Nereo Bresolin; Guglielmo Scarlato


Publisher
Springer
Year
1995
Tongue
English
Weight
899 KB
Volume
242
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Ryanodine receptor mutations in malignan
โœ Tommie V. McCarthy; Kathleen A. Quane; Patrick J. Lynch ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 259 KB ๐Ÿ‘ 2 views

Malignant hyperthermia (MH) is a pharmacogenetic disorder of skeletal muscle that manifests in response to anesthetic triggering agents. Central core disease (CCD) is a myopathy closely associated with MH. Both MH and CCD are primarily disorders of calcium regulation in skeletal muscle. The ryanodin